Back
Penumbra Vs. Repligen Industry Stock Comparison
Buy
74
PEN
Penumbra
Last Price:
$242.15
Seasonality Move:
11.69%
Sell
49
RGEN
Repligen
Last Price:
$144.48
Seasonality Move:
20.07%
Sell
49
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
-
RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PEN Stock Price Chart
PEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.31 | Buy |
Relative Strength Index (14 RSI): | 52.04 | Buy |
Chaikin Money Flow: | -379749 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.51 - 248.11) | Sell |
Bollinger Bands (100): | (186.65 - 235.65) | Buy |
RGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.12 | Buy |
Relative Strength Index (14 RSI): | 45.9 | Sell |
Chaikin Money Flow: | -1218085 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (137.16 - 156) | Sell |
Bollinger Bands (100): | (137.28 - 155.46) | Sell |
PEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 246.4 | Sell |
20-day SMA: | 245.01 | Sell |
50-day SMA: | 231.1 | Buy |
200-day SMA: | 206.5 | Buy |
8-day EMA: | 244.2 | Sell |
20-day EMA: | 242.83 | Sell |
50-day EMA: | 232.14 | Buy |
200-day EMA: | 217.16 | Buy |
RGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 153.13 | Sell |
20-day SMA: | 150.36 | Sell |
50-day SMA: | 143.82 | Buy |
200-day SMA: | 151.49 | Sell |
8-day EMA: | 150.36 | Sell |
20-day EMA: | 149.32 | Sell |
50-day EMA: | 146.14 | Sell |
200-day EMA: | 150.57 | Sell |
Penumbra Earnings Growth & PEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $1.02 per share.
Repligen Earnings Growth & RGEN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.19 per share.
Penumbra Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Repligen Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |